Previous Chapter Chapter 4: US Markets for Plaque Modification Devices Next Chapter

  • Citations
  • Add to My List
  • Text Size

US Markets for Plaque Modification Devices
US markets for plaque modification devices
Millennium Research Group, A Decision Resources, Inc. Company
Plaque Modification Overview

The plaque modification market, consisting of devices used to treat intra-vessel plaque, was valued in excess of $100 million in 2004, and consists of four main segments: coronary atherectomy devices, thrombectomy devices, embolic protection devices (EPDs), and chronic total occlusion (CTO) devices. The continual promotion of positive clinical data will augment sales of these devices over the forecast period, while patient and physician demand for less-invasive methods of plaque modification will further support the notable market growth expected through 2009. By segment, the EPD market will contribute the largest percentage of overall growth because the market is expected to more than triple in size by ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website